← FDA DRUG APPROVALS

FDA ANDA · ANDA208536

BUSULFAN

Sponsor: MYLAN INSTITUTIONAL

APPLICATION
ANDA208536
TYPE
ANDA
ORIGINAL APPROVAL
2017-11-20
LATEST ACTION
2019-08-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

BUSULFANDiscontinued
BUSULFAN 6MG/ML · INJECTABLE · INJECTION

Approval history

2019-08-12Labeling · Supplement 2 · standardAP
2019-08-12Labeling · Supplement 1 · standardAP
2017-11-20UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →